| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 04/30/1992 | WO1992007254A2 Use of disulphide bidged substances |
| 04/30/1992 | WO1992007084A1 Purified cdw52-specific antibodies |
| 04/30/1992 | WO1992007083A1 Antibodies against the urokinase receptor and their use |
| 04/30/1992 | WO1992007080A1 A eukaryotic episomal dna cloning and expression vector |
| 04/30/1992 | WO1992007077A1 Engineered bacteriophages and vaccines containing them |
| 04/30/1992 | WO1992007076A1 Modified human tnfalpha (tumor necrosis factor alpha) receptor |
| 04/30/1992 | WO1992007074A1 Polypeptide of a growth factor receptor family, application in the diagnosis and treatment of myeloproliferative diseases |
| 04/30/1992 | WO1992007073A1 Osteogenic peptides |
| 04/30/1992 | WO1992007071A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | WO1992007070A1 Transgenic rats and animal models of inflammatory disease |
| 04/30/1992 | WO1992007006A1 A solid surface coated with a hydrophilic outer layer with covalently bonded biopolymers, a method of making such a surface, and a conjugate therefor |
| 04/30/1992 | WO1992007005A1 Platelet adhesion inhibitor |
| 04/30/1992 | WO1992007004A1 Osteogenic protein |
| 04/30/1992 | WO1992007002A1 A collagen binding protein as well as its preparation |
| 04/30/1992 | WO1992007001A1 Hepatitis c virus antibody |
| 04/30/1992 | WO1992007000A1 Pharmaceutical composition for the treatment or prevention of a malignant tumor |
| 04/30/1992 | WO1992006996A1 Peptides containing substituted 1,4-diamines as transition-state inserts |
| 04/30/1992 | WO1992006990A1 Molecular clones of hiv-1 and uses thereof |
| 04/30/1992 | WO1992006989A1 Varicella-zoster virus antigen |
| 04/30/1992 | WO1992006940A1 Surface-active esther carboxylic acid derivative |
| 04/30/1992 | WO1992006705A1 Heparin binding mitogen with homology to epidermal growth factor (egf) |
| 04/30/1992 | CA2423998A1 Methods and applications for efficient genetic suppressor elements |
| 04/30/1992 | CA2094045A1 Heparin binding mitogen with egf homology |
| 04/30/1992 | CA2093919A1 Hepatitis c virus antibody |
| 04/30/1992 | CA2054149A1 Villin gene promoter sequence and its use in vectors, transformed mammalian cell lines, transgenic animals, and cell lines derived from the animals |
| 04/29/1992 | EP0483115A2 Regulatory region for heterologous gene expression in yeast |
| 04/29/1992 | EP0483113A2 A method of producing an enzymatically active polypeptide analog of human Cu/Zn SOD |
| 04/29/1992 | EP0482966A2 Stabilised derivatives of fragments of hirudin, their preparation and pharmaceutical preparations |
| 04/29/1992 | EP0482671A1 Vaccine against varicella-zoster virus |
| 04/29/1992 | EP0482649A2 CM-chitin derivatives and use thereof |
| 04/29/1992 | EP0482623A2 Smooth muscle mitogen |
| 04/29/1992 | EP0482605A2 HTLV-II derived peptide |
| 04/29/1992 | EP0482598A2 Peptide analog of human TSH receptor affective against autoimmune hyperthyroidism |
| 04/29/1992 | EP0482189A1 Receptor assay for fk-506 |
| 04/29/1992 | EP0482185A1 Cell internalizable conjugates and complexes including intracellularly cleavable moieties |
| 04/29/1992 | EP0482176A1 Monoclonal antibodies specific for toxin b of clostridium difficile |
| 04/29/1992 | EP0482144A1 Method for the recombinant production of hiridins and hirudin-like polypeptides |
| 04/29/1992 | EP0482124A1 Somatotropin analogs. |
| 04/29/1992 | EP0482097A1 Surfactant compositions and methods |
| 04/29/1992 | EP0482086A1 Antagonists of gm-csf derived from the carboxyl terminus |
| 04/29/1992 | EP0482068A1 Cytokine and hormone carriers for conjugate vaccines |
| 04/29/1992 | EP0482061A1 Dna coding for a polypeptide signal sequence in vaccinia virus |
| 04/29/1992 | EP0482053A1 Dna constructs, cells and plants derived therefrom |
| 04/29/1992 | EP0482018A1 Toxin uses |
| 04/29/1992 | CN1060680A 重组马立克氏病病毒 Recombinant Marek's Disease Virus |
| 04/28/1992 | US5109123 Alteration of ability of soluble CD4 fragments to bind HIV |
| 04/28/1992 | US5109121 Using group 2a salt to precipitate impurity |
| 04/28/1992 | US5109120 Extended blood circulation life |
| 04/28/1992 | US5109119 Concentrated and equilibrated in polyoxyethylene glycol solution |
| 04/28/1992 | US5109117 Method of somatotropin naturation using urea and a soluble organic alcohol |
| 04/28/1992 | US5109116 Plancenta extract; composed of oligosaccharide and protein |
| 04/28/1992 | US5109114 Characterization and method of isolation for an inhibitor of complement C1 |
| 04/28/1992 | US5109113 Membrane anchor fusion polypeptides |
| 04/28/1992 | US5109111 Corticotropin releasign factor |
| 04/28/1992 | US5108989 Administering transfurming growth factor-beta prior to tissue damage |
| 04/28/1992 | US5108988 Hydrogenated derivatives of antibiotic a/16686 |
| 04/28/1992 | US5108987 Transferrin or ceruloplasmin linked with arabinoside cytosine methotrexate, vincristin, daunomycin, 6-mercaptopurine and cyclophosphamide |
| 04/28/1992 | US5108923 Decapeptides |
| 04/28/1992 | US5108922 Wound healing agent, ability to induce the formation of bone and catilage; |
| 04/28/1992 | US5108921 Method for enhanced transmembrane transport of exogenous molecules |
| 04/28/1992 | US5108920 Retrovirus isolated from human lymphoma cell lines |
| 04/28/1992 | US5108919 Dna sequences encoding yeast ubiquitin hydrolase |
| 04/28/1992 | US5108918 Screening dna of host capable of producing metabolite using probes obtained from the rna or dna of bacteria or fungi lacking the ability to product the metabolite, transforming the host and cloning |
| 04/28/1992 | US5108911 Process for preparing bovine interleukin-Iβ |
| 04/28/1992 | US5108910 DNA sequences encoding fusion proteins comprising GM-CSF and IL-3 |
| 04/28/1992 | US5108901 Tissue plasminogen activator having zymogenic or fibrin specific properties |
| 04/28/1992 | US5108900 For use in immunoassay to detect pesticides in foods and the environment |
| 04/28/1992 | US5108894 Recombinant dna having a nucleotide sequence coding for protein G or fragment thereof which is capable of specific bidning with immunoglobulins |
| 04/28/1992 | US5108890 Chromogenic compounds, processes for the preparation thereof and use thereof as enzyme substrates |
| 04/28/1992 | US5108840 Multilayer electronic circuit article having a poly(naphthyl ether) dielectric |
| 04/28/1992 | US5108753 Osteogenic devices |
| 04/28/1992 | US5108745 Tuberculosis and legionellosis vaccines and methods for their production |
| 04/28/1992 | US5108744 Vaccines for Haemophilus influenzae |
| 04/28/1992 | US5108743 Administering polypeptide having human gamma interferon activity |
| 04/28/1992 | CA1299814C Mitogenic peptides |
| 04/28/1992 | CA1299812C Preparation of pharmaceutical grade amino acid chelates |
| 04/28/1992 | CA1299752C Optical decoding technique for speech recognition |
| 04/28/1992 | CA1299508C Human pancreatic elastase i |
| 04/28/1992 | CA1299507C Grf analogs |
| 04/27/1992 | WO1992007961A1 Specific detection of antibodies to human t-cell leukemia viruses |
| 04/27/1992 | WO1992007944A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | WO1992007878A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2094832A1 Specific detection of antibodies to human t-cell leukemia viruses |
| 04/27/1992 | CA2094821A1 Vaccinia vectors, vaccinia genes and expression products thereof |
| 04/27/1992 | CA2094713A1 Neutralizing human monoclonal antibodies specific for the v3 loop and cd-4 binding site of hiv-1 gp120 |
| 04/27/1992 | CA2054289A1 Smooth muscle mitogen |
| 04/26/1992 | WO1992007873A1 Production and use of tracheal antimicrobial peptides |
| 04/26/1992 | CA2091760A1 Production and use of tracheal antimicrobial peptides |
| 04/25/1992 | CA2054069A1 Expression system |
| 04/24/1992 | WO1992006994A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/24/1992 | WO1992006710A1 Immunogenic complexes, in particular iscoms |
| 04/24/1992 | CA2093672A1 Identification of a suppressor of atherogenic apolipoprotein |
| 04/23/1992 | WO1992006693A1 Dna construct for providing rna therapy |
| 04/23/1992 | DE4033369A1 Selective factor VIII recovery from plasma - using chromatographic beds of biocompatible carriers for permeation chromatography contg. plant cell wall structures etc. |
| 04/23/1992 | DE4033209A1 Oberflaechenaktive ethercarbonsaeure-derivate Oberflaechenaktive ether carboxylic acid derivatives |
| 04/23/1992 | DE4033120A1 Genomic DNA fragment encoding antibody variable region prodn. - by attaching primers to hybridoma DNA then subjecting to polymerase chain reaction, for constructing genes encoding chimeric antibodies |
| 04/23/1992 | CA2094608A1 Dna construct for providing rna therapy |
| 04/22/1992 | EP0481970A2 Monoclonal antibodies against endotoxin of gram-negative bacteria |
| 04/22/1992 | EP0481930A2 Nonlinear peptides hydropathycally complementary to known amino acid sequences, process for the production and uses thereof |
| 04/22/1992 | EP0481673A2 Genes encoding the human FK-506 binding protein and a S. cerevisiae homolog, FKB1, and their expression |